{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To accelerate visual recovery in acute optic neuritis Patient has significant visual deficit (6/12 acuity)\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection while on high-dose corticosteroids\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires confirmation of Multiple Sclerosis diagnosis (McDonald Criteria) Requires discussion of long-term risks and benefits with the patient\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To accelerate visual recovery in acute optic neuritis\", \"Patient has significant visual deficit (6/12 acuity)\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection while on high-dose corticosteroids\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires confirmation of Multiple Sclerosis diagnosis (McDonald Criteria)\", \"Requires discussion of long-term risks and benefits with the patient\"]}]"
}